Drug Shortage Report for TARO-TESTOSTERONE
Report ID | 92423 |
Drug Identification Number | 02421186 |
Brand name | TARO-TESTOSTERONE |
Common or Proper name | TARO-TESTOSTERONE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE UNDECANOATE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 120 blister |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-23 |
Estimated end date | 2019-08-30 |
Actual end date | 2019-08-30 |
Shortage status | Resolved |
Updated date | 2019-09-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-09-03 | French | Compare |
v4 | 2019-09-03 | English | Compare |
v3 | 2019-08-24 | English | Compare |
v2 | 2019-08-23 | French | Compare |
v1 | 2019-08-23 | English | Compare |
Showing 1 to 5 of 5